Dr. Reddy's Acquires MenoLabs Women’s Supplement Brand from Amyris
January 5, 2024
Dr. Reddy's Laboratories has acquired the MenoLabs dietary supplement portfolio and accompanying MenoLife health tracker app from Amyris as part of Amyris' Chapter 11 asset sale, winning the assets in an auction for $3.0 million. The acquisition adds seven branded menopause- and healthy-aging-focused supplements sold primarily via DTC e-commerce and marketplaces to Dr. Reddy's U.S. self-care and wellness portfolio to accelerate growth in women's nutritional and wellness markets.
- Buyers
- Dr. Reddy's Laboratories Ltd.
- Targets
- MenoLabs
- Sellers
- Amyris, Inc.
- Industry
- Consumer Products
- Location
- United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Amyris Acquires MenoLabs
April 12, 2022
Consumer Products
Amyris, a publicly traded synthetic biotechnology company, has acquired MenoLabs, a DTC women's wellness brand focused on perimenopause and menopause supplements and a symptom-tracking app. The deal is intended to accelerate Amyris' position in the menopause market by combining MenoLabs' subscription-based consumer business, app data, and product formulations with Amyris' fermentation technology and consumer brand capabilities.
-
Dr. Reddy's Laboratories Acquires Nimbus Health GmbH
February 22, 2022
Pharmaceuticals
Dr. Reddy's Laboratories has entered into a definitive agreement to acquire German medical cannabis pioneer Nimbus Health GmbH. Nimbus, a licensed pharmaceutical wholesaler and manufacturer based in Frankfurt, will provide Dr. Reddy's with medical-cannabis manufacturing, importing and distribution capabilities to accelerate growth in Europe.
-
HeavenlyRx Acquires 51% Stake in TRU Brands (TRUWOMEN)
July 24, 2019
Food & Beverage
HeavenlyRx Ltd. closed on the acquisition of a 51% controlling equity stake in TRU Brands, Inc. (TRUWOMEN) to accelerate its plant-based CPG and CBD wellness strategy. The deal included $3.5 million cash and $2.57 million in HeavenlyRx stock, with HeavenlyRx planning additional working capital injections to increase its stake.
-
Vision Healthcare Acquires Sensilab
April 13, 2021
Consumer Products
Vision Healthcare has agreed to acquire 100% of Sensilab d.o.o., a Ljubljana-headquartered direct-to-consumer house of consumer health brands (including Sensilab, SlimJoy, Tummy Tox and PowGen). Sensilab reported approximately €44m in net sales in 2020 and operates in-house manufacturing; the add-on strengthens Vision Healthcare’s pan‑European D2C vitamins, supplements and beauty platform and pushes group revenue above €200m.
-
Allergy Research Group Acquires Certain Assets of Metabolic Maintenance
January 15, 2025
Consumer Products
Allergy Research Group (ARG), a portfolio company backed by HPH III, has acquired certain assets of Metabolic Maintenance, a provider of physician-recommended nutritional supplements based in Sisters, Oregon. The add-on acquisition, announced by WM Partners, will integrate Metabolic Maintenance under the ARG platform to expand ARG's practitioner-channel product offering—particularly in mental well-being, stress management and mood support; terms were not disclosed.
-
FemTec Health Acquires Nutrimedy
July 25, 2022
Healthcare Services
FemTec Health has acquired Nutrimedy, an evidence-based clinical nutrition platform that offers AI-enabled photo food recognition and support for 50+ medical conditions. The acquisition adds real-time, personalized nutrition and dietitian access to FemTec's Awesome Woman subscription suite, expanding the company's women's-health capabilities.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.